These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9811765)

  • 1. Adeno-associated virus as a vector for liver-directed gene therapy.
    Xiao W; Berta SC; Lu MM; Moscioni AD; Tazelaar J; Wilson JM
    J Virol; 1998 Dec; 72(12):10222-6. PubMed ID: 9811765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-1-Antitrypsin Promoter Improves the Efficacy of an Adeno-Associated Virus Vector for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy.
    Cabrera-Pérez R; Vila-Julià F; Hirano M; Mingozzi F; Torres-Torronteras J; Martí R
    Hum Gene Ther; 2019 Aug; 30(8):985-998. PubMed ID: 30900470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.
    Song S; Embury J; Laipis PJ; Berns KI; Crawford JM; Flotte TR
    Gene Ther; 2001 Sep; 8(17):1299-306. PubMed ID: 11571566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
    Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
    Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
    Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
    Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver.
    Ohashi K; Nakai H; Couto LB; Kay MA
    Hum Gene Ther; 2005 Mar; 16(3):299-306. PubMed ID: 15812225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors.
    Hösel M; Huber A; Bohlen S; Lucifora J; Ronzitti G; Puzzo F; Boisgerault F; Hacker UT; Kwanten WJ; Klöting N; Blüher M; Gluschko A; Schramm M; Utermöhlen O; Bloch W; Mingozzi F; Krut O; Büning H
    Hepatology; 2017 Jul; 66(1):252-265. PubMed ID: 28318036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
    Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
    Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction.
    Miao CH; Nakai H; Thompson AR; Storm TA; Chiu W; Snyder RO; Kay MA
    J Virol; 2000 Apr; 74(8):3793-803. PubMed ID: 10729154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo.
    Okuyama T; Huber RM; Bowling W; Pearline R; Kennedy SC; Flye MW; Ponder KP
    Hum Gene Ther; 1996 Mar; 7(5):637-45. PubMed ID: 8845389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice.
    Xu L; Daly T; Gao C; Flotte TR; Song S; Byrne BJ; Sands MS; Parker Ponder K
    Hum Gene Ther; 2001 Mar; 12(5):563-73. PubMed ID: 11268288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse zonation of hepatocyte transduction with AAV vectors between mice and non-human primates.
    Bell P; Wang L; Gao G; Haskins ME; Tarantal AF; McCarter RJ; Zhu Y; Yu H; Wilson JM
    Mol Genet Metab; 2011 Nov; 104(3):395-403. PubMed ID: 21778099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose.
    Wu Z; Sun J; Zhang T; Yin C; Yin F; Van Dyke T; Samulski RJ; Monahan PE
    Mol Ther; 2008 Feb; 16(2):280-9. PubMed ID: 18059373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II study of intrapleural administration of a serotype rh.10 replication-deficient adeno-associated virus gene transfer vector expressing the human α1-antitrypsin cDNA to individuals with α1-antitrypsin deficiency.
    Chiuchiolo MJ; Kaminsky SM; Sondhi D; Mancenido D; Hollmann C; Crystal RG
    Hum Gene Ther Clin Dev; 2014 Sep; 25(3):112-33. PubMed ID: 25238276
    [No Abstract]   [Full Text] [Related]  

  • 16. AAV-mediated liver-directed gene therapy.
    Sands MS
    Methods Mol Biol; 2011; 807():141-57. PubMed ID: 22034029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Delivery of Alpha-1-Antitrypsin Using Recombinant Adeno-Associated Virus (rAAV).
    Song S; Lu Y
    Methods Mol Biol; 2018; 1826():183-196. PubMed ID: 30194601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of Adeno-Associated Virus-Mediated Liver Transduction Efficacy by Regional Administration in Macaca fascicularis.
    Zabaleta N; Salas D; Paramo M; Hommel M; Sier-Ferreira V; Hernandez-Alcoceba R; Prieto J; Bilbao JI; Gonzalez-Aseguinolaza G
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):68-73. PubMed ID: 28285544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing transduction of the liver by adeno-associated viral vectors.
    Nathwani AC; Cochrane M; McIntosh J; Ng CY; Zhou J; Gray JT; Davidoff AM
    Gene Ther; 2009 Jan; 16(1):60-9. PubMed ID: 18701909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
    Lieber A; Steinwaerder DS; Carlson CA; Kay MA
    J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.